Breaking News, Financial News

Financial Report: Catalent

Development and Clinical Services segment up 18% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent 4Q Revenues: $510.1 million (-2%) 4Q Earnings: $153.4 million (earnings were $27.0 million 4Q14) FY Revenues: $1.8 billion (flat) FY Earnings: $210.3 million (earnings were $15.2 million FY14) Comments: Revenue from the Oral Technologies segment was $318.8 million in the quarter, down 8% with improved performance in the softgel and modified release offerings, as well as product-participation related activities. The company recorded a one-time $6 million customer contract ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters